invivodata Announces Drug Information Association (DIA) Annual Meeting Activities

Senior Scientific and Executive Team Members to be Featured Speakers

PITTSBURGH — invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that members of its senior scientific and executive management team will be featured speakers at the Drug Information Association (DIA) 45th Annual Meeting in San Diego, CA, June 21-25, 2009.

This is the eighth consecutive year that invivodata has had a significant presence at this global industry event. Representing invivodata at this year’s meeting are:

- Dr. Jean Paty, invivodata’s senior vice president of scientific, quality, and regulatory affairs will participate in “Computerized Systems Used in Clinical Research: Best Practices from Peach – Part 2 of 2” with a presentation on “Highlights from the Chapter on Data Collection”; Tues., June 23, 4:00 pm PDT
- Doug Engfer, invivodata’s president and chief executive officer will present “The Role of eDiaries in Monitoring Patient Compliance in Clinical Trials”; Tues., June 23, 4:00 pm PDT
- Dr. Jean Paty will present “Using Handhelds to Collect Patient Data” as part of the session “Unique Challenges for Validation”; Thurs., June 25, 10:30 am PDT

In Booth No. 1706, invivodata will showcase its global ePRO solutions, including DiaryPRO® 210, its proven field-based electronic diary delivered on the Windows Mobile operating system and the Hewlett-Packard iPAQ® 210 device. invivodata will also be demonstrating its large-screen, site-based ePRO solution – the SitePRO® Tablet, which offers significant efficiencies by eliminating the time-intensive management of paper-based assessments typically completed by trial subjects during site visits.

Additionally, regulatory and scientific experts from invivodata and its consulting division, PRO Consulting™ will be available to answer questions about PRO strategy development and selecting the right PRO measures and methods to assess treatment effect in support of regulatory submissions.

For more information on invivodata’s DIA activities, please visit www.invivodata.com.

RSS Feed